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Several species of Brucella are known to be zoonotic, but 
B. neotomae infection has been thought to be limited to 
wood rats. In 2008 and 2011, however, B. neotomae was 
isolated from cerebrospinal fluid of 2 men with neurobru-
cellosis. The nonzoonotic status of B. neotomae should 
be reassessed. 
Members of the genus Brucella are the infectious agents of brucellosis, a neglected disease respon-
sible for economic losses resulting from abortion and low 
performance in production animals (1). The 4 species 
mainly responsible for this widespread bacterial zoono-
sis are B. melitensis, B. abortus, B. suis, and to a lesser 
extent B. canis. Underdiagnosis and limited awareness of 
the disease among healthcare practitioners is common in 
many countries (1).
B. neotomae, isolated in 1957 from wood rats (Neo-
toma lepida) in North America (2), has been considered 
nonzoonotic (3). It has been isolated from target organs of 
experimentally infected mice and guinea pigs (4,5). We re-
port the isolation of B. neotomae from cerebrospinal fluid 
samples from 2 human patients with neurobrucellosis.
The Study
In 2008, a Brucella sp. isolate was submitted to the Tropi-
cal Diseases Research Center at the Universidad de Costa 
Rica. This isolate (denoted strain bneohCR2) was cultured 
from a cerebrospinal fluid sample obtained from a 64-year-
old male patient at one of the main hospitals in San José, 
Costa Rica. In 2011, another isolate (denoted strain bneo-
hCR1) was recovered from a cerebrospinal fluid sample 
from a 51-year-old male patient at a regional hospital in 
Costa Rica. As is common for other patients with brucel-
losis, the blood leukocyte count for each patient was almost 
within the reference range, and C-reactive protein level was 
within reference range. Both patients showed clinical signs 
compatible with neurobrucellosis (6), had positive Rose 
Bengal test results, and recovered after receiving 1 month 
of streptomycin (750 mg/d) and 3 months of doxycycline 
(100 mg/12 h).
Further bacteriologic analysis (7,8) confirmed that the 
isolates were a Brucella sp. (Table). Real-time PCR high-
resolution melting analysis (9) confirmed genus designa-
tion but was inconclusive regarding species designation. 
Bruce-ladder multiplex PCR (10) and multiple loci variable 
number of tandem repeats–16-loci panel analysis (http://
mlva.u-psud.fr/brucella/; Figure 1) indicated that the pro-
files for both DNA isolates corresponded to profiles for B. 
neotomae. Analysis of bneohCR2 by multiplex single-nu-
cleotide polymorphism (SNP) primer extension assay (11) 
and by matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry of protein extracts (12) (online 
Technical Appendix Table 1, https://wwwnc.cdc.gov/EID/
article/23/6/16-2018-Techapp1.pdf) confirmed that the iso-
late was B. neotomae.
We performed whole-genome sequencing of bneohCR1 
and bneohCR2 and resequencing of reference strain B. neo-
tomae 5K33. Sequencing data were deposited at the Euro-
pean Nucleotide Archive (http://www.ebi.ac.uk/ena/) under 
accession codes ERS1563929 (bneohCR1), ERS1563928 
(bneohCR2), and ERS1624467 (SK33). To place the bneo-
hCR1 and bneohCR2 in a phylogenetic context, publicly 
available reads from 51 Brucella whole-genome sequences 
(online Technical Appendix Table 2) were aligned and then 
mapped to B. suis 1330 by using SMALT version 0.5.8 (ftp://
ftp.sanger.ac.uk/pub/resources/software/smalt/). Reads from 
bneohCR1 and bneohCR2 genomes mapped to 98.6% of 
the B. suis 1330 genome. SNPs were called from the align-
ment by use of Samtools (http://samtools.sourceforge.net/), 
and 34,307 variable sites across all isolates were extracted 
by using SNP sites (13). The resulting alignment of SNPs 
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was used for maximum-likelihood phylogenetic reconstruc-
tion by use of RAxML version 7.0.4 (https://github.com/
stamatak/standard-RAxML). The generated phylogenetic 
tree confirmed that the bneohCR isolates clustered together 
with B. neotomae reference strain 5K33 (ENA accession no. 
JMSC01, assembly accession no. GCA_00742255.1) (Fig-
ure 2). Isolates bneohCR1 and bneohCR2 differed from the 
reference genome by 174 and 160 SNPs, respectively. This 
number of SNPs is smaller than that between B. abortus 
9–941 and B. abortus 2308 (214 SNPs), which are 2 well-
recognized strains of the same Brucella species.
Analysis of 23 previously reported genomic islands 
or anomalous genomic loci (14) was performed for both 
bneohCR genomes. For this analysis, a “genomic-island 
pseudo-molecule” was constructed by concatenation of 23 
genomic regions obtained from different Brucella genomes. 
BLAST (https://github.com/sanger-pathogens/Farm_blast) 
comparison of this pseudo-molecule and the bneohCR draft 
genomes, generated by assembly with Velvet (15), showed 
that the genomic loci known as 26.5 kb, 12 kb, and GI-6 
that are absent in B. neotomae (14) are also absent in the 
queried genomes.
Conclusions
This report of B. neotomae as a cause of zoonotic disease 
raises questions about possible underrepresentation of re-
ported cases. This study also has implications for brucellosis 
diagnosis. Specifically, the differences among B. neotomae 
and the other Brucella species at the biochemical level are 
subtle. The major difference between B. neotomae and B. 
abortus, the main cause of human brucellosis in Costa Rica, 
is the presence of oxidase activity in B. abortus, which is 
assessed subjectively (7,8). Because B. neotomae has not, 
until now, been considered zoonotic, some cases of brucel-
losis reported as being caused by atypical zoonotic classical 
Brucella might have been misdiagnosed cases of B. neoto-
mae infection. The introduction of whole-genome sequenc-
ing into the clinical field will thus improve diagnosis. 
A lack of epidemiologic information with regard to the 
2 patients reported here precluded the investigation of ex-
posure or contact with hosts known to harbor B. neotomae. 
Further studies are needed to establish which animals may 
act as reservoirs for B. neotomae in Costa Rica.
In summary, B. neotomae should be considered a 
zoonosis risk for infection in humans. Incorporation of 
molecular techniques for diagnosis will help resolve the 
 
 
 
Table. Differential biochemical profile of Brucella isolates from 2 
men with neurobrucellosis, Costa Rica, 2008 and 2011 
Analysis bneohCR1 bneohCR2 
Biochemical tests   
 Oxidase - – 
 Citrate utilization – – 
 Nitrate reduction + + 
 CO2 required – – 
 H2S production + + 
 Urease activity, h 0–0.5+ 0–0.5+ 
Growth in presence of dyes   
 Thionin 20 g/mL – – 
 Basic fuchsin 20 g/mL – – 
Agglutination using monospecific serum  
 A + + 
 M – – 
 
Figure 1. Dendrogram based on 
multiple locus variable number 
of tandem repeats–16-loci panel 
analysis of Brucella spp.  
(http://mlva.u-psud.fr/brucella/) 
and clinical isolates from human 
cerebrospinal fluid samples 
from 2 patients with brucellosis. 
The isolates bneohCR1 and 
bneohCR2 (red branches) 
showed a pattern consistent 
with previously reported 
profiles for Brucella neotomae 
(blue shading). Black, gray, 
and tic marks are used to 
differentiate between adjacent 
species. Arrows separate small 
neighboring clusters and indicate 
the B. neotomae cluster.
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Brucella genus homogeneity obtained when only biochem-
ical assays are used.
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